Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT05615948
PHASE4
Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression
Sponsor: Theresa Jacob, PhD, MPH
View on ClinicalTrials.gov
Summary
The purpose of this study is to assess the effects of simultaneous administration of oral aspirin and oral ketamine as a therapeutic for those with Treatment Resistant Depression.
Official title: An Open-Label Clinical Trial of Simultaneous Administration of Oral Aspirin and Ketamine as Adjunct to Oral Antidepressant Therapy in Treatment-Resistant Depression
Key Details
Gender
All
Age Range
18 Years - 89 Years
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2022-12-06
Completion Date
2024-05-17
Last Updated
2026-04-21
Healthy Volunteers
No
Conditions
Treatment Resistant DepressionMajor Depressive DisorderAnalgesiaKetaminePeripheral Nervous System AgentsCentral Nervous System DepressantsNeurotransmitter AgentsAnti-Inflammatory AgentsPhysiological Effects of DrugsSensory System AgentsAnalgesics, Non-NarcoticAnti-Inflammatory Agents, Non-SteroidalDepressive Symptoms
Interventions
DRUG
VTS-K
Proprietary oral formulation of 486mg aspirin and 80mg ketamine
Locations (1)
Maimonides Medical Center
Brooklyn, New York, United States